Terapia genica in oncologia: Aspetti etici

L. M. Bucci, V. M. Fazio

Research output: Contribution to journalArticlepeer-review


The more advanced oncologic therapies are directing toward new frontiers, on account of the remarkable undesirable effects of chemio- and radio-therapies. This new therapeutic experiences are of type biological (vaccines), or genic (substitution again genes with shutters meaning-tumoral). This therapies involve, to be effected, some ethical shrewdnesses: choice of the patient, the engineering modality of the genes, the transfer of the genes in cells of the exclusively somatic line, the elimination of the pathogenic risk of the vector virus, the obligatory use of sterile rooms, the attention to the administration of the drug, a legal issue of the judgment of notoriety.

Original languageItalian
Pages (from-to)217-224
Number of pages8
JournalClinica Terapeutica
Issue number4
Publication statusPublished - Jul 2001

ASJC Scopus subject areas

  • Medicine(all)

Cite this